OFI Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

OFI Advisors’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$308K	Buy	662 +114	+21%	+$61.2K	0.02%	982
2015 Q2	$280K	Buy	548 +18	+3%	+$8.78K	0.02%	1073
2015 Q1	$239K	Sell	530 -3	-0.6%	-$1.27K	0.01%	1157
2014 Q4	$219K	Sell	533 -11	-2%	-$4.33K	0.01%	1163
2014 Q3	$196K	Sell	544 -69	-11%	-$23.1K	0.01%	1154
2014 Q2	$173K	Buy	613 +149	+32%	+$44.2K	0.01%	1236
2014 Q1	$139K	Sell	464 -15	-3%	-$4.62K	0.01%	1296
2013 Q4	$132K	Buy	479 +117	+32%	+$33.7K	0.01%	1298
2013 Q3	$113K	Sell	362 -64	-15%	-$16.8K	0.01%	1273
2013 Q2	$96K	Buy	+426	New	+$99.2K	0.01%	1282

Other funds holding REGN

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

OFI Advisors's REGN Position: Q3 2015 in Review

OFI Advisors increased its Regeneron Pharmaceuticals (REGN) stake by 21% in Q3 2015, buying an estimated $61.2K and bringing the position to 662 shares worth $308K. The position accounts for 0.02% of the portfolio, ranked #982.

OFI Advisors first reported a position in REGN in Q2 2013 and has held it in 10 quarters since. 563 funds tracked by Wall St. Rank hold REGN as of Q3 2015.

OFI Advisors held 662 shares of Regeneron Pharmaceuticals worth $308K as of Q3 2015.
OFI Advisors bought 114 Regeneron Pharmaceuticals shares in Q3 2015, an estimated $61.2K.
Regeneron Pharmaceuticals made up 0.02% of OFI Advisors's portfolio in Q3 2015, its #982 holding.
OFI Advisors first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 10 quarters since.
563 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2015.

Based on OFI Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.